Indication

Acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae

An acute exacerbation of obstructive chronic bronchitis by *Streptococcus pneumoniae* is a sudden, sustained worsening of lower respiratory symptoms in patients with underlying chronic obstructive pulmonary disease (COPD) or chronic bronchitis, driven by a bacterial infection of the tracheobronchial tree. Read more about Acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae

81 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae therapies.

Showing 28–36 of 81 drugs

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
LUPIN PHARMACEU

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
EPIC PHARMA LLC

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
AUROBINDO PHARM

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
AUROBINDO PHARM

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
ZYDUS PHARMACEU

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
RISING PHARM
Filter & compare in the drug finder →Opens the drug finder with Acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae.

An acute exacerbation of obstructive chronic bronchitis by *Streptococcus pneumoniae* is a sudden, sustained worsening of lower respiratory symptoms in patients with underlying chronic obstructive pulmonary disease (COPD) or chronic bronchitis, driven by a bacterial infection of the tracheobronchial tree.

This clinical state affects adults with pre-existing airflow limitation and is characterized by heightened airway inflammation, hypersecretion of mucus, and dynamic hyperinflation.

Pathophysiologically, proliferation of the Gram-positive pathogen *S.

pneumoniae* triggers acute neutrophilic infiltration into the bronchial mucosa, resulting in defining features that include increased dyspnea, increased sputum volume, and sputum purulence beyond the patient's baseline day-to-day variability.

Personalize your experience

Follow Acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it